← Back to Clinical Trials
Recruiting NCT07433829

NCT07433829 Prefrontal Neuroplasticity and Coping Strategies in Healthy Population

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07433829
Status Recruiting
Phase
Sponsor The Hong Kong Polytechnic University
Condition Health Adult Subjects
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2026-01-17
Primary Completion 2026-03-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Transcranial Magnetic Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2026-01-17 with a primary completion date of 2026-03-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current study serves as a pilot for the GRF project "Predicting illness trajectories in fully remitted major depression using concurrent TBS/fNIRS." The project examines whether intermittent theta-burst stimulation (iTBS) induces immediate changes in prefrontal excitability in healthy individuals, compared to sham stimulation. In this randomized, sham-controlled trial, investigators will assess several psychological measures-including the Perceived Stress Scale and the Coping Inventory for Stressful Situations-to explore how stress levels and coping strategies relate to immediate prefrontal cortex (PFC) activity changes following TBS.

Eligibility Criteria

Inclusion Criteria: * 18-60 years old; Exclusion Criteria: * a family history of psychiatric disorders; * history of or currently diagnosed neuropsychiatric conditions; * history of or active systemic illnesses such as cancer, epilepsy, diabetes, hypertension, or other medical conditions; * contraindications to transcranial magnetic stimulation (TMS); * any prior exposure to brain stimulation procedures.

Contact & Investigator

Central Contact

Georg Kranz, PhD

✉ Georg.kranz@polyu.edu.hk

📞 +85227664838

Frequently Asked Questions

Who can join the NCT07433829 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Health Adult Subjects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07433829 currently recruiting?

Yes, NCT07433829 is actively recruiting participants. Contact the research team at Georg.kranz@polyu.edu.hk for enrollment information.

Where is the NCT07433829 trial being conducted?

This trial is being conducted at Hong Kong, China.

Who is sponsoring the NCT07433829 clinical trial?

NCT07433829 is sponsored by The Hong Kong Polytechnic University. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology